Commercial Laboratory IgM Testing for Toxoplasma gondii in Pregnancy: A 20-Year Experience
Objective. This study was performed to review the clinical utility of commercial laboratory Toxoplasmosis-specific IgM testing during pregnancy and outcomes of the gestation at our institution.
Main Authors: | David J. Garry, Andrew Elimian, Vandy Wiencek, David A. Baker |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2005-01-01
|
Series: | Infectious Diseases in Obstetrics and Gynecology |
Online Access: | http://dx.doi.org/10.1080/10647440500148024 |
Similar Items
-
The role of IgM and IgG anti-toxoplasma gondii in abortion
by: Massoud A, et al.
Published: (1993-04-01) -
Frequency of anti- Toxoplasma gondii IgA, IgM, and IgG antibodies in high-risk pregnancies, in Brazil
by: Fernando Henrique Antunes Murata, et al. -
Determination of Antibodies (IgG, IgM) against Toxoplasma gondii in Patients with Cancer
by: M Pedram, et al.
Published: (2007-08-01) -
Determination of Antibodies (IgG, IgM) against Toxoplasma gondii in Patients with Cancer
by: M Ghasemian, et al.
Published: (2007-12-01) -
Detection of Anti-Toxoplasma gondii IgG and IgM Antibodies and Associated Risk Factors during Pregnancy in Southwest Iran
by: Shahrzad Soltani, et al.
Published: (2021-01-01)